A. Çömez Et Al. , "The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.," Eye (London, England) , vol.35, no.12, pp.3302-3310, 2021
Çömez, A. Et Al. 2021. The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.. Eye (London, England) , vol.35, no.12 , 3302-3310.
Çömez, A., Karaküçük, Y., Özmen, M. C., Çelemler, P., & Saygılı, O., (2021). The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.. Eye (London, England) , vol.35, no.12, 3302-3310.
Çömez, Ayşegül Et Al. "The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.," Eye (London, England) , vol.35, no.12, 3302-3310, 2021
Çömez, Ayşegül Et Al. "The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.." Eye (London, England) , vol.35, no.12, pp.3302-3310, 2021
Çömez, A. Et Al. (2021) . "The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.." Eye (London, England) , vol.35, no.12, pp.3302-3310.
@article{article, author={Ayşegül Çömez Et Al. }, title={The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity.}, journal={Eye (London, England)}, year=2021, pages={3302-3310} }